Search - tctmd.com

Displaying 141 - 160 of 219

Sort: Relevancy | Date

Presentation EuroPCR 2019

Relationship Between Residual Mitral Regurgitation and Clinical and Functional Outcomes in the COAPT Trial

Presenter: Saibal Kar

May 21, 2019

News Conference News EuroPCR 2019

MR Reduction Linked to Lower HF Hospitalizations and Deaths, Regardless of Intervention: COAPT

Shelley Wood

May 21, 2019

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Daily News

Proportionate and Disproportionate MR: A ‘Framework’ for MitraClip and Medical Therapy

Shelley Wood

May 09, 2019

News Daily News

Cardioband Reduces Severe Tricuspid Regurgitation at 6 Months, With Good Safety: TRI-REPAIR

Yael L. Maxwell

April 17, 2019

Presentation ARCH 2019

Top 10 Clinical Trials of the Past Year (Trials That Will Changed My Clinical Practice)

Presenter: David G. Rizik

April 12, 2019

Presentation ARCH 2019

The Take Home Message of COAPT

Presenter: David G. Rizik

April 12, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for March 2019

Shelley Wood

March 29, 2019

Presentation SIF 2019

The Life of a Structural Interventionalist or My Life as a Utility Player

Presenter: John M. Lasala

March 29, 2019

Presentation SIF 2019

Novel Complex Procedures and Devices: The “Known and known Unknowns "

Presenter: Morton J. Kern

March 29, 2019

Presentation SIF 2019

The Take Home Message of COAPT

Presenter: David G. Rizik

March 27, 2019

Presentation ACC 2019

Health Status after Transcatheter Mitral- Valve Repair in Patients with Heart Failure and Secondary Mitral Regurgitation: Results from the COAPT Trial

Presenter: Suzanne V. Arnold

March 18, 2019

News Conference News ACC 2019

COAPT Quality-of-Life Analysis Points to Significant, Sustained Benefits in Health Status With MitraClip

Shelley Wood

March 17, 2019

Presentation ACC 2019

Heart Failure and Secondary Mitral Regurgitation: Echocardiographic Outcomes from the COAPT trial

Presenter: Federico M. Asch

March 17, 2019

News Conference News ACC 2019

COAPT Echo Substudy in HF Patients With Mitral Regurgitation Offers New Answers, and More Questions

Shelley Wood

March 17, 2019

News Daily News

FDA Extends MitraClip Indication to Include Functional MR

Shelley Wood

March 14, 2019

News Conference News ACC 2019

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

Shelley Wood

March 11, 2019

Presentation JIM 2019

Treatment of Mitral Regurgitation in Heart Failure COAPT and beyond

Presenter: Gregg W. Stone

February 14, 2019

Presentation JIM 2019

Impact of COAPT on the Future of TMVR

Presenter: Martin B. Leon

February 14, 2019

Podcast Rox Heart Radio

TMVR - Where Do We Stand Today After COAPT and MITRA-FR, and What Does This Mean for Patients?

February 13, 2019

Advertisement

Relationship Between Residual Mitral Regurgitation and Clinical and Functional Outcomes in the COAPT Trial

MR Reduction Linked to Lower HF Hospitalizations and Deaths, Regardless of Intervention: COAPT

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Proportionate and Disproportionate MR: A ‘Framework’ for MitraClip and Medical Therapy

Cardioband Reduces Severe Tricuspid Regurgitation at 6 Months, With Good Safety: TRI-REPAIR

Top 10 Clinical Trials of the Past Year (Trials That Will Changed My Clinical Practice)

The Take Home Message of COAPT

TCTMD’s Top 10 Most Popular Stories for March 2019

The Life of a Structural Interventionalist or My Life as a Utility Player

Novel Complex Procedures and Devices: The “Known and known Unknowns "

The Take Home Message of COAPT

Health Status after Transcatheter Mitral- Valve Repair in Patients with Heart Failure and Secondary Mitral Regurgitation: Results from the COAPT Trial

COAPT Quality-of-Life Analysis Points to Significant, Sustained Benefits in Health Status With MitraClip

Heart Failure and Secondary Mitral Regurgitation: Echocardiographic Outcomes from the COAPT trial

COAPT Echo Substudy in HF Patients With Mitral Regurgitation Offers New Answers, and More Questions

FDA Extends MitraClip Indication to Include Functional MR

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

Treatment of Mitral Regurgitation in Heart Failure COAPT and beyond

Impact of COAPT on the Future of TMVR

TMVR - Where Do We Stand Today After COAPT and MITRA-FR, and What Does This Mean for Patients?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content